Fewer dollars, more sense
- PMID: 18854564
- DOI: 10.1200/JCO.2008.17.9564
Fewer dollars, more sense
Comment on
-
Bevacizumab plus irinotecan in recurrent glioblastoma multiforme.J Clin Oncol. 2007 Oct 20;25(30):4722-9. doi: 10.1200/JCO.2007.12.2440. J Clin Oncol. 2007. PMID: 17947719 Clinical Trial.
Similar articles
-
Bevacizumab and recurrent malignant gliomas: a European perspective.J Clin Oncol. 2010 Apr 20;28(12):e188-9; author reply e190-2. doi: 10.1200/JCO.2009.26.9027. Epub 2010 Feb 16. J Clin Oncol. 2010. PMID: 20159801 No abstract available.
-
Bevacizumab-induced diffusion restriction in patients with glioma: tumor progression or surrogate marker of hypoxia?J Clin Oncol. 2010 Sep 20;28(27):e477; author reply e478. doi: 10.1200/JCO.2010.29.2029. Epub 2010 Jun 28. J Clin Oncol. 2010. PMID: 20585096 No abstract available.
-
Mechanisms of evasion to antiangiogenic therapy in glioblastoma.Clin Neurosurg. 2010;57:123-8. Clin Neurosurg. 2010. PMID: 21280504 No abstract available.
-
Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates.Expert Rev Anticancer Ther. 2006 Nov;6(11):1593-607. doi: 10.1586/14737140.6.11.1593. Expert Rev Anticancer Ther. 2006. PMID: 17134364 Review.
-
Topoisomerase I inhibitors for the treatment of brain tumors.Expert Rev Anticancer Ther. 2008 May;8(5):707-16. doi: 10.1586/14737140.8.5.707. Expert Rev Anticancer Ther. 2008. PMID: 18471044 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical